Search

Pseudomonas plecoglossicida is a Gram-negative bacterium that causes chronic granulomatous diseases in fish. However, the molecular mechanisms underlying its pathogenicity are poorly understood. Here, we identified a novel two-component system (TCS) named PvgAS in P. plecoglossicida , which regulates the expression of genes including the type VI secretion system-1 (T6SS-1), a key virulence factor, as well as the type III secretion system (T3SS) gene cluster and several genes associated with metabolic pathways. We showed that PvgAS is essential for bacterial virulence in large yellow croaker (LYC), an important aquaculture species, by controlling T6SS-1 expression, which is crucial for tissue colonization and intracellular survival. In contrast, T3SS was dispensable for P. plecoglossicida virulence in this model. We also confirmed T6SS-1 gene regulation by PvgAS at the transcriptional and translational levels using RNA-seq, RT-qPCR, lacZ reporter, and western blot assays. Our study reveals a regulatory and functional role of PvgAS in P. plecoglossicida pathogenicity and suggests that PvgAS may be a potential target for new therapeutic interventions against this bacterium. • Identified a novel two-component system PvgAS in Pseudomonas plecoglossicida. • PvgAS regulates type III and type VI secretion systems and bacterial virulence. • T3SS is dispensable but T6SS-1 is essential for P. plecoglossicida pathogenicity. • PvgAS is a potential target for developing new therapeutic interventions. [ABSTRACT FROM AUTHOR]

Pseudomonas plecoglossicida is a facultative Gram-negative bacteria that causes 'visceral granulomas disease' (VGD) in large yellow croaker (LYC; Larimichthys crocea) and several other fish species leading to high economic losses. Currently, there are no commercial vaccines against VGD. Thus, we evaluated the efficacy of a live attenuated vaccine (LAV) made by our laboratory in LYC administered orally in alginate-coated LAV-loaded feeds. To evaluate the tolerance of the LAV in the acidic environment of the stomach, we treated the alginate-coated LAV with a simulated gastric juice without pepsin. There was a 10-fold decrease in the number of viable LAV cells after treatment with the simulated gastric juice (pH 2.0). Despite so, we found a significant increase in LAV cells in the liver and hindgut within 4 h post first feeding of oral vaccine (hpff), which increased to high levels by 24 hpff indicating that LAV cells that survived the stomach acidic environment reached the hindgut for adsorption. Although there was a transient change in the composition of the gut microbiota at 24 hpff, analysis using the Shannon and β-diversity indices showed a similarity in the bacterial composition found before and after vaccination indicating that the LAV had no long-term adverse effect on the gut microbiota. Systemic and mucosal humoral responses were characterized by high serum antibody levels and upregulation of the pig and sign while activation of cell-mediated immunity was characterized by upregulation of MHC-Iα, MHC-IIβ, Prf1 and IFNγ genes. The overall protection in vaccinated LYC was estimated at relative percent survival (RPS) of 60%. Altogether, this study has shown that LAVs can be used as oral vaccines to confer protective immunity without impacting adverse effects on the fish microbiota. • P. plecoglossicida causes 'visceral granulomas disease' (VGD) in large yellow croaker. • This is the first report of a promising live attenuated vaccine against VGD by oral administration. • Oral vaccination confers protective immunity without impacting adverse effects on the fish microbiota. [ABSTRACT FROM AUTHOR]

Pseudomonas plecoglossicida is an important pathogenic bacterial species in aquaculture, causing visceral granulomas in large yellow croaker (Larimichthys crocea) and several other economically important fish species. The GacS/GacA is a two-component regulatory system (TCS) primarily found in Pseudomonads for its role in virulence, quorum sensing, and biofilm formation. To investigate the potential role of GacS/GacA system of P. plecoglossicida , a gacS deficient mutant (Δ gacS) was generated based on a clinical isolate XSDHY-P. Compared to the wild-type (WT) strain, the Δ gacS strain showed almost no growth defect in vitro but was impaired in swimming motility and biofilm formation. Furthermore, the Δ gacS strain exhibited significantly more sensitivity to the bactericidal action of normal fish serum mediated by the complement system. In a cell model originating from the head-kidney of large yellow croaker, the Δ gacS showed lower capacities of adhesion, invasion, and intracellular survival compared to the WT strain. In addition, the virulence of the Δ gacS and WT bacterial strains were evaluated in large yellow croaker. The results showed that the deficiency of gacS drastically decreased bacterial tissue loads and substantially attenuated P. plecoglossicida virulence in fish. Furthermore, a comparative transcriptome was performed between the Δ gacS and WT strains by RNA-sequencing (RNA-seq). Transcriptomic analysis results revealed 25 upregulated and 273 downregulated genes in the Δ gacS strain compared with the WT strain, and the downregulated genes were mainly involved in flagellar assembly, metabolism, bacterial chemotaxis, and biofilm formation, which are consistent with their respective phenotypic traits. These findings will provide functional insight into the role of GacS/GacA in P. plecoglossicida. • The Δ GacS was impaired both in swimming motility and biofilm formation compared to the P. plecoglossicida WT strain. • The GacS plays a contributing role in the adhesion an invasion to LYC-hK, and in immune escaping of P. plecoglossicida. • Deletion of the GacS gene drastically attenuated the virulence of P. plecoglossicida to fish. • The results of the comparative transcriptomic analysis are consistent with their respective phenotypic traits. [ABSTRACT FROM AUTHOR]